Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.

Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ. Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals. AIDS Res Hum Retroviruses. 2011 May; 27(5):461-8.

View in: PubMed

subject areas

Adult
Alkynes
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
Benzoxazines
C-Reactive Protein
Cyclopropanes
Dideoxynucleosides
Female
HIV Infections
Humans
Male
Middle Aged
Sex Factors

authors with profiles

Cecilia M. Shikuma,MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support